RNF38

Across TCGA pan-cancer cohorts, RNF38 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RNF38 data layer compared with 26 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher RNF38 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated RNF38 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

PDAC and HNSC are the cancer types where RNF38 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Quartile	All	0.305	0.745	.007	30	view →
HNSC	DFS	Quartile	All	0.704	0.441	.035	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RNF38–PDAC (OS)

Open the PDAC breakdown →